His scientific interests lie mostly in Stroke, Genome-wide association study, Genetics, Pathology and Internal medicine. His Stroke study integrates concerns from other disciplines, such as Coronary artery disease, Dementia, Disease, Vascular disease and Ischemia. His research in Genome-wide association study intersects with topics in Meta-analysis, Case-control study, Genetic association and Bioinformatics.
His Genetics research is multidisciplinary, incorporating elements of Familial hemiplegic migraine and Migraine. His research integrates issues of White matter, Magnetic resonance imaging and Hyperintensity in his study of Pathology. His study explores the link between Internal medicine and topics such as Cardiology that cross with problems in Cerebral infarction.
Stroke, Internal medicine, Pathology, CADASIL and Disease are his primary areas of study. The various areas that Martin Dichgans examines in his Stroke study include Vascular disease, Genome-wide association study, Dementia and Blood pressure. His studies deal with areas such as Case-control study, Genetic association and Bioinformatics as well as Genome-wide association study.
Mendelian randomization is closely connected to Cardiology in his research, which is encompassed under the umbrella topic of Internal medicine. Martin Dichgans studied Pathology and Hyperintensity that intersect with Lesion. His Disease study frequently draws connections between related disciplines such as Neuroscience.
The scientist’s investigation covers issues in Internal medicine, Disease, Stroke, Cardiology and Mendelian randomization. His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology and Oncology. Martin Dichgans combines subjects such as Neuroscience and Bioinformatics with his study of Disease.
Martin Dichgans interconnects Meta-analysis, Lesion and Genome-wide association study in the investigation of issues within Stroke. His Hyperintensity research extends to Genome-wide association study, which is thematically connected. His Mendelian randomization study combines topics from a wide range of disciplines, such as Odds ratio, Body mass index, Genetic predisposition, Confidence interval and Genetic association.
Martin Dichgans focuses on Disease, Internal medicine, Stroke, Cardiology and Neuroscience. His research in the fields of Dementia and Cognitive decline overlaps with other disciplines such as Medium term. His study looks at the relationship between Internal medicine and fields such as Immune system, as well as how they intersect with chemical problems.
His Stroke research includes elements of Odds ratio, Mendelian randomization, Obesity and Etiology. His Cardiology study combines topics in areas such as Endovascular treatment and Logistic regression. The study incorporates disciplines such as Tau pathology and Patient centered in addition to Neuroscience.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The International Classification of Headache Disorders, 3rd edition (beta version)
Jes Olesen;André Bes;Robert Kunkel;James W. Lance.
Cephalalgia (2013)
Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (Nature Genetics (2009) 41 (1088-1093))
D Harold;R Abraham;P Hollingworth;R Sims.
Nature Genetics (2013)
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
Joanna M. Wardlaw;Eric E. Smith;Geert J Biessels;Charlotte Cordonnier.
Lancet Neurology (2013)
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.
Denise Harold;Richard Abraham;Paul Hollingworth;Rebecca Sims.
Nature Genetics (2009)
National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards
Vladimir Hachinski;Costantino Iadecola;Ron C. Petersen;Monique M. Breteler.
Stroke (2006)
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
Paul Hollingworth;Denise Harold;Rebecca Sims;Amy Gerrish.
Nature Genetics (2011)
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
Joanna M Wardlaw;Colin Smith;Martin Dichgans;Martin Dichgans.
Lancet Neurology (2013)
Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine.
Martin Dichgans;Tobias Freilinger;Gertrud Eckstein;Elena Babini.
The Lancet (2005)
The phenotypic spectrum of CADASIL: clinical findings in 102 cases.
M. Dichgans;M. Mayer;I. Uttner;R. Brüning.
Annals of Neurology (1998)
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.
Lesley Jones;Peter A. Holmans;Marian L. Hamshere;Denise Harold.
PLOS ONE (2010)
University of Cambridge
Harvard University
Université Paris Cité
University of Oxford
Boston University
deCODE Genetics (Iceland)
University of Edinburgh
Erasmus University Rotterdam
Mayo Clinic
University of Washington
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: